Pixilab
Home › Companies › SEC Form D - Biotechnology › Sapience Therapeutics, Inc.

Sapience Therapeutics, Inc.

SEC Form D private-offering issuer in Biotechnology

Sapience Therapeutics, Inc. is a company in sec form d - biotechnology based in Scarsdale, NEW YORK, founded in 2015.

Profile

Private US issuer recorded in the SEC Form D structured dataset for 2016Q1. Industry: Biotechnology. Revenue range: Decline to Disclose. Offering amount: 1000000.

The company sits in the sec form d - biotechnology segment, where it competes on its core product or service.

The company is recorded as being based in Scarsdale, NEW YORK.

It is recorded at the Regulation D stage.

Recorded headcount: 11-50 employees.

Total disclosed funding stands at about $1M.

SectorSEC Form D - Biotechnology
HeadquartersScarsdale, NEW YORK
CountryUnited States
Founded2015
Employees11-50
StageRegulation D
Total funding$1,000,000

Website: sapiencetherapeutics.com

Browse related

More SEC Form D - Biotechnology companies Companies in United States Companies founded in 2015
Emails and contact routes are reserved for registered members.
Create a free account